– On track to initiate FIH study with STRO-004, potential best-in-class Tissue Factor ADC, in the second half of 2025 –
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights
Seeking Alpha / 1 hour from now 1 Views
Seeking Alpha / 1 hour from now 1 Views
– On track to initiate FIH study with STRO-004, potential best-in-class Tissue Factor ADC, in the second half of 2025 –
Comments